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Abstract
Ionic liquids (ILs) deﬁned as organic salts that produced from combination of organic cation with various types of
organic/inorganic anions whose melting point less than 100  C. Because of their ionic character, most of ionic liquids
exhibit useful properties such as no volatility, recyclability, good thermal stability, high conductivity and chemical
stability. Ionic liquid cationeanion combinations permits the solvents to be prepared such as N, N-dialkylimidazolium
as cation and acetate as anion. Ionic liquid was utilized as solvents or preparation components in various areas of drug
delivery systems, also as novel liquid forms of APIs in various stages of design drug delivery systems. Also their
incorporation with polymers has enabled the development of drug delivery systems for new therapeutic routes of
administration. Recently ionic liquid can be used as solubility and permeability enhancer to deliver drugs with poor
aqueous solubility and low lipophilicity by designing topical drug delivery of nano system.
Keywords: Active pharmaceutical ingredients(APIs), Ionic liquid, Topical drug delivery system, Solubility and permeability enhancer

1. Introduction

I

n the formulation of drug as a dosage form,
organic solvents usually utilized for enhancing
the solubility of active pharmaceutical ingredients
APIs during the in vitro study of drugs and during in
vivo study in an investigating the biological effects of
drug on targets and using large quantities of organic
solvents constitutes a major health concerns [1].
Recognition of the exact solvents or co-solvents
needs to know the purposed route of administration
[2]. In such case the choosing of a solvent that act as
a vehicle to improve the solubility and enhance
permeation result in good bioavailability of drug, it's
an attractive replacement to follow up, although its
biocompatible. Using of salts that are in liquid state
at room temperature currently called ionic liquids
(ILs) [3]. Ionic liquids (ILs) considered as organic
salts were produced from combination of asymmetric cation with various types of anions whose
melting point less than 100  C, over the last few

years, (ILs) have gained signiﬁcant and growing
interest in a variety of research genera such as engineering ﬂuids, food sciences, synthetic chemistry
and pharmaceutical sciences due to their useful
properties such as no volatility, recyclability, thermal stability and high conductivity, so considered as
greener solvent in contrast with traditional organic
solvents [4]. Recently, utilizing of these solvents in
pharmaceutical applications attributable to their
changeable physicochemical properties like polarity, viscosity and catalytic role in the synthesis of
pharmaceutical ingredient (PI) and, the most interested, good ability for solubilization of hydrophilic
and hydrophobic drugs [5]. So, ionic liquids (ILs) is
regarded a novel solvent in pharmaceutical delivery
system and formulation of active pharmaceutical
ingredient (API) due to unparalleled and tunable
physicochemical and biological properties, also utilizing of ILs can improve the pharmacokinetic and
pharmacodynamics properties of drugs [6]. Moreover, the incorporation of active ingredients that act
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as cations or anions in synthesis of ILs encourage
the transformation of active ingredient from solid
into a liquid state (API-ILs). Polymorphism concerns
will overcome by this strategy, provides improved
solubility and enhanced therapeutic efﬁcacy [7,8].
Confer elasticity in formulation of API-ILs, also it is
probable to enhance the permeation of APIs across
membranes, this employed for mixing of permeation enhancers with APIs and for utilizing a combination of surfactant with ionic liquid as excipients
with novel design [9]. To improve delivery systems
of drugs, the formulation of modern systems utilizing polymers with biopolymers was performed by
employing ionic liquid as polymerization processes
media specially for polymers have opportunity for
in situ functionalization [10,11].
1.1. Advantages of ionic liquids
Ionic liquids have several important advantages
[12], and according to these advantages ionic liquid
considered as a green solvent, which are:
1-Ionic liquids have high polarity.
2-Ionic liquid remain liquid over a wide range of
temperature.
3-Ioinc liquids are non-volatile and possess low
vapor pressure.
4-Ionic liquid are mostly hydrophilic in nature
and rarely hydrophobic.
5-Ionic liquids are thermally stable and resist high
temperature up to 300  C.
6-Ionic liquid have high electrical conductivity.
7-Ionic liquids are incompatible with organic
solvents.
1.2. Limitations of ionic liquids
The use ILs have disadvantages such as toxicity
due to possibility of release these compounds into
water courses or soil. Estimation the risks of ILs,
numerous ILs have had their toxicity assessed toward several micro- and macro-organisms over the
past few decades. Since the toxic effects of ILs
depend on the method of estimating toxicity, it is
necessary to brieﬂy summarize and comprehensively discuss the biological effects of ILs according
to their structure and toxicity testing levels [13].
However, some ILs are produced from non-renewable energy sources and are poorly biodegradable in
the environment, undermined their green character,
when designing and synthesizing new chemical
products as suggested in the 3rd, 4th and 10th green
chemistry principles, not only their efﬁciency and
cost should be considered, but also their toxicity to
human health and environment [14]. ILs becomes

permanent pollutants and possess hazard to the
environment, also high cost of ionic liquid making
them impractical for large scale industrial applications like metal electroplating, biocatalyst and electrodeposition. Therefore, the main challenges in the
application of conventional ILs has been the cost
issues and availability. Myriad issues like availability and toxicity will limit their practical use for larger
scale applications of other metals and biomaterials
[15].
1.3. Properties of ionic liquid
Properties of ionic liquid include melting point,
density, thermal stability, volatility, viscosity, and
solubility of materials rely on alternatives on
organic component and by the counter ion. Ions
variation can be performed to adjust their chemical
and physical properties, ﬁne tuning of properties is
probable by changing the length and branching of
the alkyl groups incorporated into the cation.
Abundant of ionic liquids have even been advanced
for speciﬁc synthetic problems. For this reason,
ionic liquids have been termed “designer
solvents” [16].
1.3.1. Melting point
Ionic liquids should be liquid at room temperature when used as a substitute to organic solvents,
hence the melting point of ionic liquid must be that
of water in order to work with them at room temperature. The melting point magnitude is present
related to the composition and structure of ionic
liquids. Hence, careful selection of cation and anion
in preparation of ionic liquid determines its melting
point [17].
1.3.2. Density
Density of ionic liquid determined by anion and
cation that were utilized in preparation of ionic
liquid. The density ionic liquids are between 1.0 and
1.35 gcm 3, which observed practically. Organic
anion bulkiness found in ionic liquid determines its
density. As bulkiness increase, density tends to
decrease [18].
1.3.3. Thermal stability
Solvents that were used in the synthesis must be
thermally stable at any temperature of the working.
Ionic liquids have good stability compared to
organic solvents, and found to be stable at or above
400  C. Anion in ionic liquid responsible greatly for
thermal stability of liquids when compared to cations. Thermal stability of ionic liquids may decrease
with anion hydrophilicity [19].
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1.3.4. Viscosity
The viscosity of ionic liquid should be intermediate when compared with viscosity of organic solvents, that mean neither low viscous nor high
viscous that make ionic liquid difﬁcult to handle or
hard to mix with the substances that were used at
starting of synthesis [20].
1.3.5. Volatility
The main problem that present in organic solvent
is volatility, that make them reduplicate the process
which can be prevented by using of ionic liquids,
because most of these liquids are non-volatile, the
process repeatability is low [21].
1.4. Purity ionic liquids
The presence of impurities in the ionic liquids
cause changes in the physical and chemical properties of these liquids, so the ionic liquids puriﬁcation is necessary. The most pollutants of ionic
liquids are halides or organic and water based
substrates, that usually produced from unreacted
materials (ionic liquid precursors that remain unchanged to the end). Ionic liquids have ability to
absorb moisture, so hydrophobic ionic liquids are
moisture-absorbing. Generally, drying of ionic liquids were performed by heating under vacuum, but
it is difﬁcult to remove water completely because of
hydrogen bonding). Reducing the density and
modulating the chemical properties of ionic liquids
in presence of water [22,23].

1.7. Cation and anions of ionic liquids
The cation of ionic liquid composited of an
organic structure with positive charge. The most
utilized cations in ionic liquids are nitrogen or
phosphorous containing organic ions. The presence
of cation in ionic liquid usually inﬂuence the physical and chemical properties of them. Anion of ionic
liquid consists of negatively charged weakly basic
compound, which may be an organic or inorganic.
The common anions of ionic liquids are nitrate,
acetate, borate or sulphate ions [26]. Some examples
of cation and anion present in ionic liquids are given
in (Table 1).

2. Applications of ionic liquids in drug
delivery
2.1. Ionic liquid as solvents of active
pharmaceutical ingredients (APIs)

The pyridinium and methylimidazolium ions
considered as good starting step to develop of ILs.
The common ILs precursor structure based on alkyl
imidazolium and pyridinium ions. Preparation of
conventional ILs by use of N-alkylimidazole has
been made by the reaction of 1-methylimidazole
with butyl chloride in the presence of acetonitrile as
catalyst usually was applied towards the end of the
last century [24].

Active pharmaceutical ingredients (APIs) that are
poorly soluble in aqueous media usually solubilized
in organic liquids such as ethanol or dimethyl sulfoxide) during pharmaceutical preparation [27]. ILs
was investigated as promising solvents, co-solvents,
in addition to their use as surfactant can improve
the solubility of active ingredients, utilizing of ionic
liquid as substitutional liquids were ﬁrstly performed by Jaitely et al., 2008 [28], using ionic liquid
based on imidazolium for solubilizing dexamethasone and progesterone. Then various studies
determined the improvement of solubility by
different orders of extent for analgesic, antifungal
and chemotherapeutic drugs by utilizing ionic
liquid and comparing to their water solubility [29].
Careful selection of ionic liquid cations and anions
has conﬁrmed to instruct the solubilization mechanism of active ingredient with poor aqueous solubility and ionic liquid solvation mechanism.
Hydrophilicelipophilic balance between the components of ionic liquid encourages the formation of
systems and solubilizing agents to enhance the
water solubility of active ingredients of various

1.6. Preparation of protic ionic liquid

Table 1. Examples of cations and anions used in ionic liquid.

1.5. Preparations of conventional ionic liquid

Researchers reported alternative procedure to
manufacture ILs through acidic reactions by using
protonator such as strong acids. Due to high proton
activity of strong acid, they become as alternative
method to metathesis reaction, such as sulfuric acid
that utilized for reactions including N-alkylimidazoles [25].

Cations

Anions

N, N-dialkylimidazolium
Alkylphosphonium
Alkylammonium
Pyrazolium
Thiazolium
Triazolium
N-alkylpyridium

Acetate
Hexaﬂuorphosphate
Tetraﬂuroborate
Methylsulfate
Hexaﬂuroantimonate
Chloride, bromide and iodide
Nitrate
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pharmacological classes [30]. Moira M et al., 2020
prepare Ionic-Liquid-in-Water nanoemulsions toward systemic delivery of amphotericin B, amphotericin B (AmB) is an agent that poses a challenge for
intravenous drug delivery due to its hydrophobicity
and severe side effects that are attributed to the selfaggregation of AmB in aqueous solution, ionicliquid-in-water nano emulsion drug delivery system
that harnesses the unique properties of ionic
liquids. The complex drug AmB serves as a model
pharmaceutical agent to demonstrate the robustness
of ionic-liquid-in-water nanoemulsions. High concentrations of AmB were solubilized in a new
hydrophobic dicholinium-based ionic liquid. The
absorption spectrum of AmB in an ionic liquid
mixture and prepared nanoemulsion indicates AmB
solubilization in the monomeric form. The hydrophobic ionic liquid exhibits high in vivo biocompatibility [31]. J C Riedl et al., 2022 develop a design
of concentrated colloidal dispersions of iron oxide
nanoparticles in ionic liquids, explain that the system under study consists of iron oxide nanoparticles
(NPs) dispersed in ethylmethylimidazolium, the
thermal stability of these nanoparticle dispersions is
then analyzed on the short and long term up to
200  C, ionic liquid-based colloidal dispersions of
iron oxide NPs in an ionic liquid stable over years at
room temperature can be obtained [32].

Thus, this strategy solves the problem of polymorphism and provides improved bioavailability,
and ideally boosts therapeutic properties [36].
Moreover, in comparison with powder forms of
APIs, the liquids exceed energy barrier concerned
with the enthalpy of fusion, exhibiting good solubility in water and consequently good therapeutic
activity [37]. Ionic liquid gives an indication that
improvement the physical stability and enhancement drug solubility and permeability regarded as a
promising application. Appropriate selection of the
ILs constituents permits active pharmaceutical
ingredient use as cations or anions, resulting in
liquid state drugs (API-ILs). The ﬁrst development
of API-ILs was performed by stoimenovski et al.,
2011 [38,39], with design of ranitidinium docusate
([Ran][Doc]), which enhanced API absorption and
present as liquid at room temperature [40]. This
invention opened the way for obtaining new forms
of APIs with dual pharmacological activity [41,42].
These ionic liquids also can be produced by
employing of the strategy of prodrug to one ion of
API-IL, that mean including a compound with inert
biological activity and undergoes conversion into
active compound of API-IL either by enzyme or by
introducing the free acid/base of the conjugate
base/acid within the formulation of the salt [43].

2.2. Liquid forms of APIs

2.3. Ionic liquid as permeation enhancers and
microemulsion components

Bioavailability and therapeutic efﬁcacy of poorlywater soluble APIs represents problem, as result,
the APIs may defeat in last stages of preparation or
constitute side effects associated with their precipitation [33]. Furthermore, APIs in solid form may
exhibit various bioavailability proﬁles correlated
with incident of various polymorphs, which would
comprise an issue when polymorph is inadequate,
that mean highest toxicity is administrated [34]. So,
active ingredients formation in liquid forms can be
useful design to prevent such problems. Ionic liquid
is inert and display a set of unique features, from
which is possible to highlight, if properly designed,
their high thermal and chemical stability and a
strong solvation ability for a wide variety of compounds, also low volatility and tunable properties
which can be adjusted by properly selecting the
nature of hydrogen bonding pairs to display a wide
liquid range, water ecompatibility, non-ﬂammability and biocompatibility or biodegradability [35].
The proper selection of cationeanion combinations
in ILs enables the use of drugs as ion components,
allowing for the conversion of solid active pharmaceutical ingredients into liquid forms (API-ILs).

The improvement of permeation of APIs across the
biological membranes can be obtained by combining
permeation enhancers with APIs through APLs-IL
design approach, this approach ﬁrstly developed by
Megwa et al., 2000 [44], that combine anion of salicylate with cation of quaternary ammonium to
enhance the permeability of the active ingredients
across skin. Following this work, different studies
accomplished to enhance salicylates permeability
across biological membranes, recorded as novel salicylate-ILs and ionic liquid with of poly (ethylene
glycol) derivatives [45]. The careful selection of
biocompatible cations, like amino acids, has been
also considered for this purpose [46]. The prolinium
ethylester ibuprofenate (API-IL) showed permeation
improvement of active ingredient approximately ten
times through the skin of pig compared to its solubilized form in ethanol solution, without signiﬁcant
toxicity to ﬁbroblast cells [47]. Furthermore, ionic
liquid preparations were developed to present
tunable lipophilic-hydrophilic character, that mean
increasing the aqueous solubility and improving the
permeability of active ingredient across the biological
membranes, such ionic liquid designated as surface-
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active ionic liquids (SAILs) have been regarded as
modern drug carriers and the achievement of these
liquids compared with traditional surfactants, with
ﬁrst exhibiting superior ability [48,49]. The membrane perturbation is depending on alkyl chain hydrophobicity that present in anion and cation of ionic
liquid. After these elucidations, ILs were investigated
concerning their ability for ﬂuidizing the cell membranes; ionic liquid with hydrophobic characteristics
like imidazolium based-IL cause destabilization of
membranes and create channels across the biological
membranes for transporting of API, while ionic
liquid with hydrophilic characteristics lead to an
opposite behavior [50]. So careful selection of the
ionic liquid composition and therapeutic target result
in enhancement transdermal delivery of different
active pharmaceutical ingredients without disclosing
the membrane impartiality with the IL hydrophobic/
hydrophilic balance [51,52] Outright the probability
of forming micelles using SAILs has been inspected
to develop intravenous, topical and transdermal delivery [53,54]. In previous delivery route, microemulsion can be produced by ionic liquid.
Microemulsions are colloidal dispersion of oil and
water that stabilized by surfactant molecules [55].
Ionic liquids could be the promising substituent for
oil, aqueous phase, and surfactant, enhancing the
permeability of APIs across biological membranes
[56]. C. Wang et al.2018 prepare ionic liquid-microemulsions for the transdermal delivery of dencichine.
Two imidazaolium based ionic liquid were used in
the study which are 1-hydroxyethyl-3-methylimidazolium chloride ([HOEIM]Cl) and 1-butyl-3methylimidazolium
dodecanesulfate
([BMIM]
C12SO3) were combined with aqueous and surfactant phases respectively for enhancement of permeation across the skin. The nano-system was
optimized depending on a pseudo-ternary phase
diagram. The optimized formula consists of 50%
water phase/[HOEIM]Cl mix (1:1), 20% Tween 80/
[BMIM]C12SO3 mix (1:1) as surfactant, 10% propylene glycol as co-surfactant and 20% IPM as oil phase.
Microemulsion characterizations are droplets sizes
(47.7 ± 1.5 nm), pH (6.71 ± 0.04), zeta potential
( 14.83 ± 3.64 mV) and viscosity (31 ± 4 mPa). In-vitro
assay of skin permeation indicates better enhancement of ILs preparation on the topical delivery of
dencichine, which was approximately 10-fold that of
the drug aqueous solution. Moreover, in-vivo pharmacodynamics evaluation suggested better hemostatic activity of dencichine by the topical application
of the vehicle [57]. So, the present study suggested
that the ionic liquid microemulsion regarded as
a promising nano-scale vehicle for the topical
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application of drug to obtain a desirable pharmacological activity effects.

3. Conclusion
Ionic liquids considered as competitive alternatives for using of organic solvents and surfactants to
enhance active ingredient solubility for delivery of
drugs. Enhanced solubility that obtained by utilizing of ionic liquid s are various demand of extent
higher in comparison to those that produced in an
aqueous medium, viable to special types of APIs. In
spite of these favorable results, comprehensive
studies concerning drug stability in ionic liquid
medium, while processing their storage for long
term, and the in vivo test of bioavailability for these
preparations are still required. Moreover, other
classes of ionic liquid must be inspected, especially
considering ionic liquid with biocompatible properties, also the exceedingly inspected imidazoliumbased. The set cationeanion blend of ionic liquid
also permitted new drugs in liquid form to achieved
with enhanced physical, chemical and biological
properties such as preventing the polymorphism
concerns and enhancing the solubility through
overcome the enthalpy energetic barrier of melting,
so enhancing bioavailability. Ionic liquid was
developed to produce either single activity or double therapeutic response and enable an administration by various routes. Utilizing of ionic liquid as
enhancer for permeability and as microemulsions
components that act as oil, surfactant or water
phase has increased topical and transdermal delivery of various classes of drugs, allowing good
permeation across biological membranes. Studies
deﬁciency on improvement of therapeutic action
and unknown information about the pharmacokinetic and pharmacodynamics parameters of ionic
liquid and IL-APIs after administration still prevents their envisaged commercial application.
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